The results indicate that miR-130b plays an oncogenic role in ESCC cells by repressing PTEN expression and Akt phosphorylation, which would be helpful in developing miRNA-based treatments for ESCC. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.